Biologics
Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
Published in Lab Business Week, March 2nd, 2008
The econometric study by economist Dr. Robert J. Shapiro, former Under Secretary of Commerce in the Clinton Administration, found that "...generic versions of the top 12 categories of biologic treatments with patent protections that have expired or that are due to expire in the near future could save Americans $67 billion to $108 billion over 10 years and $236 billion to $378 billion over 20 years."
According to other published reports, an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2008-03-02)
More Articles from Lab Business Week
- Anxiety Disorders
40 Million Americans Endure Anxiety Everyday - Bird Flu
Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration - Bone Research
Unigene Announces Publication of Initial Results of Site-Directed Bone Growth Studies - Clinical Trial Research
Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin - Coagulation
CLSI Publishes Guideline for the Collection, Transport, and Processing of Blood Specimens for Coagulation Assays - Drug Delivery
Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
